Fig. 2
From: The microRNA-6510 as a potential tumor suppressor in head and neck cancer
Impact of hsa-miR-6510-3p on cell cycle of (A) FaDu and (B) H103 cells. Flow cytometry and statistical analysis. Data presented as percentages of cells in the G1, S, and G2-M phases. NC – cells transfected with non-specific, control miRNA; miR-6510 inh – cells transfected with hsa-miR-6510-3p inhibitor; miR-6510 - cells transfected with hsa-miR-6510-3p; d5 – cells analyzed on the 5th day after transfection; d7 – cells analyzed on the 7th day after transfection. Data are presented as the mean ± standard deviation. ns – statistically non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ****p < 0.00001 with comparisons indicated in the table.
